Synthesis of two labeled forms of proteasome inhibitor MLN273

被引:3
|
作者
Plesescu, Mihaela [1 ]
Ll, Yuexian [1 ]
Prakash, Shimoga R. [1 ]
机构
[1] Millennium Pharmaceut Inc, Dept Drug Metab & Pharmacokinet, Cambridge, MA 02139 USA
来源
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2007年 / 50卷 / 5-6期
关键词
C-14]MLN273; morpholine-4-[C-14]Carbonyl chloride; D-8]MLN273; L-[D-8]naphthylalanine;
D O I
10.1002/jlcr.1176
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:428 / 430
页数:3
相关论文
共 50 条
  • [11] SYNTHESIS OF TWO ISOTOPICALLY LABELED VERSIONS OF AURORA A KINASE INHIBITOR
    Li, Yuexian
    Prakash, Shimoga R.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (5-6): : 448 - 450
  • [12] Prediction of the human pharmacokinetics (PK) and pharmacodynamics (PD) of MLN9708, an investigational proteasome inhibitor
    Blakemore, S. J.
    Bulychev, A.
    Berger, A.
    Yu, S.
    Paton, M.
    Cardoza, K.
    Riordan, W.
    Berg, D.
    Stathis, A.
    Yu, L.
    EJC SUPPLEMENTS, 2010, 8 (07): : 199 - 199
  • [13] Synthesis of analogs of the proteasome inhibitor belactosin A
    Dunlap, Norma
    Fitzsimonds, Zackary
    Stephenson, Ariel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [14] Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
    Augello, Giuseppa
    Modica, Martina
    Azzolina, Antonina
    Puleio, Roberto
    Cassata, Giovanni
    Emma, Maria Rita
    Di Sano, Caterina
    Cusimano, Antonella
    Montalto, Giuseppe
    Cervello, Melchiorre
    CELL DEATH & DISEASE, 2018, 9
  • [15] Antitumor Activity of MLN9708, a Second-Generation Proteasome Inhibitor, in Preclinical Models of Lymphoma
    Donelan, Jill
    Bannerman, Bret
    Bano, Kristen
    Babcock, Trisha
    Hales, Paul
    Stringer, Bradley
    Burke, Kristine
    Danaee, Hadi
    Faron-Yowe, Laura
    Koenig, Erik
    Lichter, David
    Kupperman, Erik
    BLOOD, 2009, 114 (22) : 1434 - 1435
  • [16] Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
    Giuseppa Augello
    Martina Modica
    Antonina Azzolina
    Roberto Puleio
    Giovanni Cassata
    Maria Rita Emma
    Caterina Di Sano
    Antonella Cusimano
    Giuseppe Montalto
    Melchiorre Cervello
    Cell Death & Disease, 9
  • [17] The synthesis of two furan-based analogues of the α′,β′-epoxy ketone proteasome inhibitor eponemycin
    Bennacer, B
    Trubuil, D
    Rivalle, C
    Grierson, DS
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2003, 2003 (23) : 4561 - 4568
  • [18] Preclinical evalution of the orally active proteasome inhibitor MLN9708 in preclinical models of human cancer
    Kupperman, Erik
    Berger, Allison
    Yu, Li
    Tsu, Christopher
    Frank, Bruzzese
    Liu, Jane
    Blank, Jonathan
    Larry, Dick
    Paul, Fleming
    Cao Yueying
    Bannerman, Bret
    Fitzgerald, Mike
    Zhang, Julie
    Yu, Jie
    Hales, Paul
    Manfredi, Mark
    Bolen, Joe
    Rolfe, Mark
    CANCER RESEARCH, 2009, 69
  • [19] An enantioselective formal synthesis of the proteasome inhibitor (+)-lactacystin
    Green, MP
    Prodger, JC
    Hayes, CJ
    TETRAHEDRON LETTERS, 2002, 43 (37) : 6609 - 6611
  • [20] Association of K-Ras Genotype with Xenograft Tumor Response to the Investigational Proteasome Inhibitor MLN9708
    Chattopadhyay, N.
    DiBacco, A.
    Garnsey, J.
    Bannerman, B.
    Hales, P.
    Yu, J.
    Mulligan, G.
    Koenig, E.
    Berger, A.
    Manfredi, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 69 - 69